Application of longitudinal item response theory models to modeling Parkinson’s disease progression-Reference-Cited by-同舟云学术

Application of longitudinal item response theory models to modeling Parkinson’s disease progression

Published:2022-08-09 Issue:10 Volume:11 Page:1382-1392
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacom & Syst Pharma

Author:

Zou Haotian¹^ORCID,Aggarwal Varun²^ORCID,Stebbins Glenn T.³,Müller Martijn L. T. M.²^ORCID,Cedarbaum Jesse M.⁴,Pedata Anne²,Stephenson Diane²,Simuni Tanya⁵,Luo Sheng⁶

Affiliation:

1. University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

2. Critical Path Institute Tucson Arizona USA

3. Rush University Medical Center Chicago Illinois USA

4. Coeruleus Clinical Sciences LLC Woodbridge Connecticut USA

5. Northwestern University Medical Center Chicago Illinois USA

6. Duke University Durham North Carolina USA

Funder

National Institute on Aging

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12853

Reference34 articles.

1. Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update

2. Help cure Parkinson’s disease: please don’t waste the Golden Year;Hauser RA;npj Park Dis,2018

3. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

4. The Parkinson Progression Marker Initiative (PPMI)

5. Tracking Parkinson’s: Study Design and Baseline Patient Data

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sparse item testing of clinical scales in neurology trials to alleviate burden to patients;Journal of Neurology;2024-08-30

2. Tips and tricks in tremor treatment;Journal of Neural Transmission;2024-07-24

3. Supplementing Best Care with Specialized Rehabilitation Treatment in Parkinson’s Disease: A Retrospective Study by Different Expert Centers;Journal of Clinical Medicine;2024-05-20

4. Prediction of Individual Disease Progression Including Parameter Uncertainty in Rare Neurodegenerative Diseases: The Example of Autosomal-Recessive Spastic Ataxia Charlevoix Saguenay (ARSACS);The AAPS Journal;2024-04-30

5. Assessing tilavonemab efficacy in early Alzheimer's disease via longitudinal item response theory modeling;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2024-04